Furthermore, recent data suggest that GRK2 kinase activity activates nuclear factor 'kappa-light-chain-enhancer' of activated B-cells (NF-κB), thus participating in cardiac hypertrophy [26]. The gene discussed is NFKB1; the disease is cardiac hypertrophy.